Array Biopharma Inc
ARRY
ARRY was delisted on the 29th of July, 2019.
128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
51% less call options, than puts
Call options by funds: $396K | Put options by funds: $809K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GC
126
Globeflex Capital
San Diego,
California
| $1K | +$1.44K | +267 | New |
|
127
Dimensional Fund Advisors
Austin,
Texas
| $1K | +$1.61K | +300 | New |
|
|
PFG
128
Piershale Financial Group
Barrington,
Illinois
| – | +$586 | +109 | New |
|
ARRY Hedge Fund Activity: Q2 2013 in Review
128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q2 2013, worth a combined $447M.
Buyers outnumbered sellers: 128 funds opened new ARRY positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.
- 128 institutional investors held Array Biopharma Inc (ARRY) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $447M of Array Biopharma Inc stock for Q2 2013.
- 128 funds opened new Array Biopharma Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.
Based on aggregated 13F filings for Q2 2013.